Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Lewis

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Differential gene expression identifies novel markers of CD4+ and CD8+ T cell activation following stimulation by Mycobacterium tuberculosisJacqueline M Cliff, Iryna N J Andrade, Rohit Mistry, et al.
Microbiology (Reading, England)|October 9, 2002
Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulenceRuth A McAdam, Selwyn Quan, Debbie A Smith, et al.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Differential gene expression identifies novel markers of CD4+ and CD8+ T cell activation following stimulation by Mycobacterium tuberculosisJacqueline M Cliff, Iryna N J Andrade, Rohit Mistry, et al.
Microbiology (Reading, England)|October 9, 2002
Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulenceRuth A McAdam, Selwyn Quan, Debbie A Smith, et al.
Mabs|April 29, 2020
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodiesMartin J Scott, Amanda Jowett, Martin Orecchia, et al.
Pageof 2